Moderna

Open: 104.61 Close: 104.26 Change: -0.35

Can you guess what an AI found about Moderna.

The game is changing. There is a new strategy to evaluate Moderna fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: vaccine, Moderna, study, combination, say, Modernas, strong, and the …

Concept Map

Semantic Network

Stock Summary

Moderna, Inc. discovers, develops, and commercializes messenger RNA therapeutics and vaccines. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV.

Today's Summary

Moderna hopes to get approval for a combined flu vaccine by 2025. The two-in-one vaccine also appeared to have a similar safety profile.

Today's News

Moderna and Pfizer vaccines are both based on mRNA technology. Novavax takes a different approach to the protein-based flu vaccine. Moderna hopes to get approval for a combined flu vaccine by 2025. Modernas flu-Covid combo vaccine elicits ‘strong immune response in phase 1/2 study, company says. Moderna is also developing a combination shot targeting the flu and RSV. Biotech and Pharma Modernas Combo Vaccine Moves Towards Late-Stage Trial. Moderna announced positive results from its phase 1/2 trial of a combination vaccine against influenza and COVID-19. Modernas flu-Covid combo vaccine elicits ‘strong immune response in phase 1/2 study, company says. The two-in-one vaccine also appeared to have a similar safety profile to the Covid-19. Moderna said its combination vaccine generated a strong immune response compared to individual shots for the viruses in an early-stage study. Moderna isnt the only company that has been studying a two-in-one combination vaccine. Moderna said its combination vaccine to protect against both COVID-19 and influenza generated a strong immune response compared to individual shots for the viruses in an early-stage study. Moderna also said the combination was found to be safe and tolerable, and rates of adverse side effects were similar to those experienced by people who received its COVID vaccine during the study. Health departments in Bryan, Camden, Effingham, Liberty, Long, and McIntosh Counties have limited availability of the COVID-19 vaccine by Moderna for individuals without health insurance coverage. Moderna Biotechnology Research Cambridge, Massachusetts, is pioneering a new class of medicines made of messenger RNA. Every cell in the body uses messenger RNA to provide real-time instructions to make proteins necessary to drive all aspects of biology. Moderna has been named a top biopharmaceutical employer by Science for the past eight years. Modernas mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing.

Stock Profile

"Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella-zoster virus, and human immunodeficiency virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts."

Keywords

This document will help you to evaluate Moderna without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Moderna are: vaccine, Moderna, study, combination, say, Modernas, strong, and the most common words in the summary are: vaccine, moderna, job, news, covid19, best, stock, . One of the sentences in the summary was: The two-in-one vaccine also appeared to have a similar safety profile.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #vaccine #moderna #job #news #covid19 #best #stock.